Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Risk Screening Ultimately Reduces Overall Healthcare Costs & Improves Results

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for the early diagnosis of disease is risk screening. So if risk screenings are so valuable, why don’t patients take advantage of these preventative services more often? Let’s take a look.

The High Cost of Waiting

Studies have shown that early detection of certain cancers and other chronic diseases through screening can reduce mortality by 15 to 20 percent. Not only does risk screening prevent complications by diagnosing health conditions early, it can actually help patients—and the healthcare system as a whole—save money. For example, in 2012 Alan Katz, Executive Vice President of SeeChange Health, testified that the average annual cost of early-stage treatment of breast cancer for a single patient is about $14,000 per year compared with $61,000 for late-stage treatment. Other examples of risk screening procedures that help drive down healthcare costs include colonoscopiespulmonary embolism risk assessment, and screenings for obesity, and tobacco and alcohol use.

So Why Isn’t Risk Screening Used More Often?

Out of pocket insurance costs are a top reason more people don’t schedule risk screenings. According to Thompson Reuters, the costs of mammograms, colonoscopies, and MRIs for Americans with employer-sponsored insurance can be two to three times higher than the median price in the same market. In addition, patients may simply be unaware of the specific risk screenings that are available to them because they do not regularly communicate with a primary care physician. Finally, when a patient does decide to get a screening, they may find the process for scheduling an appointment cumbersome and time-consuming.

ChartLogic Has the Tools to Make Scheduling Risk Screenings Easier

ChartLogic’s Connect Patient is a multifunction patient portal and communications platform that works with any device or browser. Physicians and patients can use this powerful technology tool to quickly and easily engage, enhancing the overall patient experience and improving quality by allowing patients to be more active participants in their own care. Patients can easily schedule appointments, send and receive messages from their doctor, view lab results, request prescription refills, and make payments. Best of all, Connect Patient integrates with ChartLogic’s comprehensive ambulatory EHR suite that includes Electronic Medical Records, Practice Management, and Billing Services.

Read more at chartlogic.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512